Weight-loss supplements are rebranding as “GLP-1 boosters.” They’re nothing like Ozempic. If you had come across the ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...

In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

No signal for an increase in suicidal ideation or attempts associated with GLP-1 use was seen across subgroups stratified by ...

A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

The future of the weight loss market might not revolve around GLP-1 drugs.

Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...